Biologic treatment eligibility and characteristics of Romanian patients with severe asthma: Real-world data from the RECOGNISE study
References
- Global Initiative for Asthma. Global strategy for asthma management and prevention. 2022. Available from: http://ginasthma.org/wp-content/uploads/2022/07/GINA-Main-Report-2022-FINAL-22-07-01-WMS.pdf [Accessed 8th January 2023].
- Song P, Adeloye D, Salim H, Dos Santos JP, Campbell H, Sheikh A, et al. Global, regional, and national prevalence of asthma in 2019: a systematic analysis and modelling study. J Glob Health. 2022;12: 04052. doi:10.7189/jogh.12.04052
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396: 1204–1222. doi:10.1016/S0140-6736(20)30925-9
- Eurostat. Finland: EU country with highest share of asthmatics. 2021. Available from: http://ec.europa.eu/eurostat/web/products-eurostat-news/-/edn-20210924-20210921. [Accessed 8th January 2023.]
- Caminati M, Senna G. Uncontrolled severe asthma: starting from the unmet needs. Current Medical Research and Opinion. 2019;35: 175–177. doi:10.1080/03007995.2018.1528218
- Rogliani P, Calzetta L, Matera MG, Laitano R, Ritondo BL, Hanania NA, et al. Severe asthma and biologic therapy: when, which, and for whom. Pulmonary Therapy. 2020;6: 47–66. doi:10.1007/s41030-019-00109-1
- Roche N, Garcia G, de Larrard A, Cancalon C, Bénard S, Perez V, et al. Real-life impact of uncontrolled severe asthma on mortality and healthcare use in adolescents and adults: findings from the retrospective, observational RESONANCE study in France. BMJ Open. 2022;12: e060160. doi:10.1136/bmjopen-2021-060160
- Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology. 2014;43: 343–373. doi:10.1183/09031936.00202013
- Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology. 2020;55: 1900588. doi:10.1183/13993003.00588-2019
- Agache I, Akdis CA, Akdis M, Canonica GW, Casale T, Chivato T, et al. EAACI biologics guidelines-recommendations for severe asthma. Allergy. 2021;76: 14–44. doi:10.1111/all.14425
- Frix AN, Heaney LG, Dahlén B, Mihaltan F, Sergejeva S, Popović-Grle S, et al. Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study. ERJ Open Research. 2022;8: 00273–2022. doi:10.1183/23120541.00273-2022
- Porsbjerg CM, Menzies-Gow AN, Tran TN, Murray RB, Unni B, Audrey Ang SL, et al. Global variability in administrative approval prescription criteria for biologic therapy in severe asthma. The Journal of Allergy and Clinical Immunology: In Practice. 2022;10: 1202–16.e23. doi:10.1016/j.jaip.2021.12.027
- Kanniess F, Tamasi L, Mroz RR, Bakakos P, Tubis S, Plat GR, et al. Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE). European Respiratory Journal. 2021;58: A3729. doi: 10.1183/13993003.congress-2021.PA3729
- Global Initiative for Asthma. Pocket guide for asthma management and prevention. A pocket guide for health professionals. Updated 2017. Available from: http://ginasthma.org/wp-content/uploads/2017/02/wms-Main-pocket-guide_2017.pdf [Accessed 8th January 2023.]
- Jones PW, Quirk FH, Baveystock CM. The St. George’s respiratory questionnaire. Respiratory Medicine. 1991;85(Suppl B): 25–31. doi:10.1016/S0954-6111(06)80166-6
- Juniper EF, Svensson K, Mörk AC, Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respiratory Medicine. 2005;99: 553–558. doi:10.1016/j.rmed.2004.10.008
- Yang CC, Fong Y, Lin LC, Que J, Ting WC, Chang CL, et al. The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery. 2018;53: 235–240. doi:10.1093/ejcts/ezx215
- Albers FC, Müllerová H, Gunsoy NB, Shin JY, Nelsen LM, Bradford ES, et al. Biologic treatment eligibility for real-world patients with severe asthma: the IDEAL study. The Journal of Asthma: Official Journal of the Association for the Care of Asthma. 2018;55: 152– 160. doi:10.1080/02770903.2017.1322611
- Jeimy S, Tsoulis MW, Hachey J, Kim H. Eligibility of monoclonal antibody-based therapy for patients with severe asthma: a Canadian cross-sectional perspective. Allergy, Asthma, and Clinical Immunology. 2018;14: 68. doi:10.1186/s13223-018-0301-6
- Marques Mello L, Viana KP, Moraes Dos Santos F, Saturnino LTM, Kormann ML, Lazaridis E, et al. Severe asthma and eligibility for biologics in a Brazilian cohort. The Journal of Asthma: Official Journal of the Association for the Care of Asthma. 2021;58: 958– 966. doi:10.1080/02770903.2020.1748049
- Bakakos P, Tryfon S, Palamidas A, Mathioudakis N, Galanakis P. Patient characteristics and eligibility for biologics in severe asthma: results from the Greek cohort of the RECOGNISE “real world” study. Respiratory Medicine. 2023;210: 107170. doi:10.1016/j.rmed.2023.107170
- Bumbacea D, Panaitescu C, Bumbacea RS. Patient and physician perspectives on asthma and its therapy in Romania: results of a multicenter survey. Medicina (Kaunas). 2021;57: 1089. doi:10.3390/medicina57101089
- Chen W, Sadatsafavi M, Tran TN, Murray RB, Wong CBN, Ali N, et al. Characterization of patients in the international severe asthma registry with high steroid exposure who did or did not initiate biologic therapy. Journal of Asthma and Allergy. 2022;15: 1491–1510. doi:10.2147/JAA.S377174
- Shaw DE, Sousa AR, Fowler SJ, Fleming LJ, Roberts G, Corfield J, et al. Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology. 2015;46: 1308–1321. doi:10.1183/13993003.00779-2015
- Heffler E, Blasi F, Latorre M, Menzella F, Paggiaro P, Pelaia G, et al. The severe asthma network in Italy: findings and perspectives. The Journal of Allergy and Clinical Immunology: In Practice. 2019;7: 1462–1468. doi:10.1016/j.jaip.2018.10.016
- Kim MH, Kim SH, Park SY, Ban GY, Kim JH, Jung JW, et al. Characteristics of adult severe refractory asthma in Korea analyzed from the severe asthma registry. Allergy, Asthma & Immunology Research. 2019;11: 43–54. doi:10.4168/aair.2019.11.1.43
- Agache I, Beltran J, Akdis C, Akdis M, Canelo-Aybar C, Canonica GW, et al. Efficacy and safety of treatment with biologics ( benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines – recommendations on the use of biologics in severe asthma. Allergy. 2020;75: 1023–1042. doi:10.1111/all.14221
- Bousquet J, Humbert M, Gibson PG, Kostikas K, Jaumont X, Pfister P, et al. Real-world effectiveness of omalizumab in severe allergic asthma: a meta-analysis of observational studies. The Journal of Allergy and Clinical Immunology: In Practice. 2021;9: 2702–2714. doi:10.1016/j.jaip.2021.01.011
- Charles D, Shanley J, Temple SN, Rattu A, Khaleva E, Roberts G. Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: a systematic review and meta-analysis. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology. 2022;52: 616–627. doi:10.1111/cea.14112
Language: English
Page range: 105 - 118
Published on: Aug 29, 2024
Published by: Romanian Society of Pneumology
In partnership with: Paradigm Publishing Services
Publication frequency: Volume open
Related subjects:
© 2024 Dragos Nicolosu, Dragos Gabriel Ungureanu, Violeta Perlea, Corina-Elena Horodniceanu, Mirela Tudorache, Bogdan Mincu, Adriana Stoica, Gabriela Teodorescu, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.